Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens

Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens

Copyright 2001 Academic Press.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 100(2001), 1 vom: 10. Juli, Seite 40-8
1. Verfasser: Nordøy, T (VerfasserIn)
Weitere Verfasser: Kolstad, A, Tuck, M K, Aaberge, I S, Husebekk, A, Kaminski, M S
Format: Aufsatz
Sprache:English
Veröffentlicht: 2001
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, U.S. Gov't, P.H.S. Antibodies, Monoclonal Antigens, Bacterial Antigens, CD20 Antigens, Neoplasm Antigens, Viral Immunoglobulins Iodine Radioisotopes tositumomab I-131 K1KT5M40JC